Nasus Pharma (NSRX) announced the execution of comprehensive agreements with Aptar France S.A.S. and AptarGroup (ATR) to support the ongoing clinical development and planned commercialization of NS002 ...
Nasus Pharma has filed for an initial public offering. The pharmaceutical company plans to offer 1 million units at $10 to $12 apiece for total proceeds of up to $12 million, according to a filing ...
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The latest announcement is out from Nasus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback